From: Risk of valvular heart disease associated with use of fenfluramine
Author, year | Duration (months) | "Incident" cases | Expected cases | p-value by Poisson | Relative Risk (RR) | Lower 95% CI of RR | Upper 95% CI of RR | z | p-value |
---|---|---|---|---|---|---|---|---|---|
Khan, 1998 | 26.5 | 38.9 | 1.939 | <0.00001 | 59.5 | 31.6 | 112.1 | 12.7 | <0.00001 |
4.9 | 3.5 | 0.086 | <0.00001 | 69.1 | 31.1 | 153.4 | 10.4 | <0.00001 | |
9.0 | 5.6 | 0.125 | <0.00001 | 108.0 | 57.1 | 204.4 | 14.4 | <0.00001 | |
Weissman, 1998 | 2.4 | 11.6 | 0.696 | <0.00001 | 15.3 | 8.4 | 27.9 | 8.9 | <0.00001 |
Shively, 1999 | 6.9 | 9.3 | 0.685 | <0.00001 | 38.4 | 18.9 | 78.0 | 10.1 | <0.00001 |
Hensrud, 1999 | 9.6 | 3.3 | 0.075 | <0.00001 | 7.8 | 1.2 | 51.8 | 2.1 | 0.016 |
Ryan, 1999 | 16.7 | 13 | 0.600 | <0.00001 | - | - | - | - | - |
Gardin, 2000 | 2.0 | 0.03 | 0.042 | 0.96 | 0.7 | 0.0 | 61295 | -0.1 | 0.52 |
4.5 | 10.3 | 0.226 | <0.00001 | 47.8 | 31.3 | 73.0 | 17.9 | <0.00001 | |
9.0 | 8.2 | 0.459 | <0.00001 | 18.8 | 10.6 | 33.3 | 10.0 | <0.00001 | |
15.0 | 10.5 | 0.563 | <0.00001 | 19.5 | 11.6 | 32.9 | 11.2 | <0.00001 | |
22.0 | 14.5 | 0.816 | <0.00001 | 18.7 | 11.6 | 30.0 | 12.1 | <0.00001 | |
2.0 | 0 | 0.080 | 0.92 | 0.0 | 0.0 | - | -0.3 | 0.60 | |
4.5 | 7.5 | 0.359 | <0.00001 | 26.1 | 15.0 | 45.2 | 11.6 | <0.00001 | |
9.0 | 16.2 | 0.652 | <0.00001 | 31.0 | 20.6 | 46.7 | 16.5 | <0.00001 | |
15.0 | 2.8 | 0.190 | 0.0010 | 18.5 | 7.6 | 45.1 | 6.4 | <0.00001 | |
Jollis, 2000 | 2.0 | 0.10 | 0.022 | 0.022 | 5.1 | 0.0 | 1233 | 0.6 | 0.28 |
4.5 | 2.8 | 0.618 | 0.026 | 4.8 | 1.6 | 14.9 | 2.8 | 0.0029 | |
9.0 | 14.1 | 1.638 | <0.00001 | 9.3 | 5.4 | 15.9 | 8.1 | <0.00001 | |
18.0 | 31.7 | 2.486 | <0.00001 | 13.8 | 9.2 | 20.6 | 12.7 | <0.00001 | |
30.0 | 11.9 | 1.131 | <0.00001 | 11.4 | 6.6 | 19.7 | 8.7 | <0.00001 | |
Davidoff, 2001 | 2.5 | 5.0 | 0.300 | <0.00001 | 20.8 | 9.9 | 43.4 | 8.1 | <0.00001 |
Summary, 2002 | 8.78 | 220.8 | 14.01 | <0.00001 | 19.6 | 16.3 | 23.5 | 31.7 | <0.00001 |